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ABSTRACT The aim of this study was to examine the use of pedometers as a tool to promote daily
physical activity levels in patients with COPD.
A systematic review meta-analysis of pedometer physical activity promotion in patients with COPD was
conducted. Medline/PubMed, Cochrane Library, Web of Science and CINAHL were searched from
inception to January 2019. The search strategy included the following keywords: physical activity
promotion, pulmonary rehabilitation and daily physical activity. The eligibility criteria for selecting studies
were randomised controlled trials reporting pedometer physical activity promotion in patients with COPD.
Improvements in steps per day were found with pedometer physical activity promotion either standalone
(n=12, mean 0.53 (95% CI 0.29–0.77); p=0.00001) or alongside pulmonary rehabilitation (n=7, 0.51 (0.13–0.88);
p=0.006). A subgroup analysis reported significant differences in the promotion of physical activity based
on baseline physical activity levels and the type of instrument used to assess levels of physical activity.
Future trials should consider the way in which pedometers are used to promote physical activity to
inform clinical practice in the setting of pulmonary rehabilitation.
Introduction
Interventions to promote levels of daily physical activity are becoming important in the management of
patients with COPD [1, 2]. Studies comparing the levels of physical activity in patients with COPD with
healthy age-matched controls have reported significantly lower levels in those with COPD [3–5]. In
addition, low levels of physical activity in patients with COPD are associated with an increased risk of
hospitalisation and mortality [3, 6, 7]. Therefore, effective approaches to improve daily physical activity are
needed in patients with COPD.
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Pulmonary rehabilitation has shown substantial improvements in exercise tolerance; however, these findings
have not consistently progressed into improvements in daily physical activity [8]. One reason for this may
link to physical activity being a complex health behaviour, with the determinants of physical activity
influenced by personal, interpersonal, environmental, regional and/or national and global factors [9].
Physical activity promotion through the use of pedometers encompasses the stimulation of patients
towards higher levels of daily physical activity by modifying their behaviour, with many versions of this
intervention also using elements of the self-regulatory theory [10]. This theory involves a process of
guiding an individual’s own thoughts, behaviours and feelings towards achieving specific goals [11].
Incorporating the use of pedometers as a real-time feedback tool for improving daily steps allows patients
the ability to follow individualised physical activity goals, which can be assessed and improved alongside
techniques of motivational interviewing [12].
Implementing behaviour strategies using pedometer feedback can be done a number of ways, including
face-to-face contact between patients and clinicians, group contact during rehabilitation sessions and
through electronic information and communication technologies (tele-coaching) [13].
Studies have, however, provided inconsistent findings towards the implementation of pedometer-based
feedback and motivational interviewing as part of physical activity promotion [14, 15]. Moreover, when the
same intervention was added to standard care pulmonary rehabilitation, results remained inconclusive [1].
The most updated systematic review and meta-analysis has found high levels of heterogeneity regarding
physical activity promotion, both as a standalone intervention and alongside pulmonary rehabilitation [1].
The existence of such heterogeneity is predominantly due to both methodological variables (types of goal
setting, provided feedback and length of intervention) and patient demographics (severity and baseline
physical activity levels). Hence, the aim of this systematic review and meta-analysis was to elucidate on
aspects of physical activity promotion related to the way that pedometers are used to optimise physical
activity in patients with COPD. In this context, we investigated the optimal frequency of goal setting, the
type of patient feedback, the optimal length of interventions, the type of instrument used for assessing
physical activity, and associations between baseline activity levels and the magnitude of improvement in
daily physical activity.
Review objective
The aim of this review was to systematically review and meta-analyse aspects of physical activity
promotion, specifically regarding how pedometers are used to optimise physical activity in interventions
which incorporate the use of pedometers as a key component for improving levels of daily physical activity
in patients with COPD.
Methods
The Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) [16] guidelines for reporting systematic review and
meta-analyses were followed when conducting and reporting this prospectively registered systematic review
(identifier CRD42018103893; www.crd.york.ac.uk/prospero/).
Eligibility criteria
The review team conducted a computerised literature search beginning in March 2018 in the following
databases: Medline/PubMed, Cochrane Review, Web of Science and CINAHL. The final search of the
literature took place on 18 January, 2019. Pre-piloted literature searches prior to the final search strategy
were conducted based on two previously published systematic reviews on a related topic [1, 17]. The full
search strategy can be found in table 1. It included a wide range of modalities; using terms associated with
“chronic obstructive pulmonary disease”, “physical exercise training”, “physical activity promotion,
physical activity counselling” and “randomized controlled trial”. Bibliographic details of all articles from
the different databases were stored in the reference software file EndNote.
On completion of the literature search, all stored references were exported from EndNote to the systematic
review management software programme, Covidence. Eligible studies published in the English language
were included if they fulfilled the predetermined PICOS criteria. 1) Population/participants: individuals
with COPD defined by spirometry (i.e. forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC)
<0.7). 2) Interventions or exposures: patients with COPD who were enrolled onto a programme of physical
activity promotion, which included the use of a tool that provides real-time feedback on steps per day (i.e.
pedometer screen). This included standalone interventions or those incorporated into pulmonary
rehabilitation. 3) Comparison or control groups: patients not receiving any physical activity promotion
intervention. 4) Outcomes of interest: the effect of physical activity promotion on steps per day as a
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measure of daily physical activity. 5) Setting: certified research studies. 6) Study design: randomised
controlled trials (RCTs), both arms (intervention plus control).
Data extraction
After removing the duplicates and based on the inclusion criteria, two authors (M. Armstrong and
N. Chynkiamis) independently and blinded, reviewed the title and abstract of trials and assessed the full
text of articles. Any possible disagreement between both authors during the study selection process was
discussed with a third author (I. Vogiatzis) for resolution.
For each eligible study, a pre-designed standardised Microsoft Excel form was used to collect data by a
single author (M. Armstrong) on the following subheadings: author information (including name of first
author and date of publication), blindness, participant characteristics (including age, FEV1 % pred, FVC,
6-min walk distance (6MWD), baseline daily steps, total lung capacity and residual volume, intervention
details, physical activity measurements, primary outcomes and results). Two blinded reviewers (M.
Armstrong and N. Chynkiamis) screened all articles independently, any disagreements were sent to a third
independent author (I. Vogiatzis) to make a majority agreement.
Quality assessment
Quality assessment was performed using the PEDro quality scale, which is an 11-item scale assessing
internal and external validity of clinical trials [18]. Two authors (M. Armstrong and N. Chynkiamis)
independently reviewed the following domains employed by this scale: eligibility criteria, random
allocation, concealed allocation, baseline similarity, blinding (subject, therapist and assessor), and measures
recorded from at least 85% of participants, full intention to treat, group comparison and point measure.
The higher the given score, the better the quality. Cut-off points of the scale were excellent (9–10), good
(6–8), fair (4–5) and poor (<3) [18].
Data synthesis
Meta-analyses were undertaken using Review Manager (RevMan v.5.3; Cochrane Collaboration, Oxford,
UK). Change scores or end of intervention values with the corresponding standard deviation for the
outcomes of interest were used to obtain the overall effect size represented by standard mean difference
with 95% confidence interval, with a threshold p<0.05 considered as significant. Heterogeneity in this
meta-analysis was assessed by I2 value as follows: 0–40%, might not be important; 30%–60%, moderate
heterogeneity; 50%–90% substantial heterogeneity; and 75%–100% considerable heterogeneity [19]. A
fixed-effects model was used for the meta-analysis; however, if statistical heterogeneity was noted (I2
>40%), meta-analyses were performed using the random effects model. Sensitivity analysis was used if
substantial heterogeneity (I2 >75%) was reported in meta-analyses.
TABLE 1 Search criteria for computerised literature search conducted in PubMed
Search Query
1 (“Chronic obstructive pulmonary disease” [Text Word] OR “COPD” [Text Word] OR “Chronic Lung
Disease” [Text Word] OR “Chronic Obstructive Lung Disease” [Text Word] OR “Emphysema”
[Text Word] OR “Chronic Bronchitis” [Text Word])
2 (“exercise” [Text Word] OR “rehabilitation” [Text Word] OR “exercise training” [Text Word] OR
“pulmonary exercise training” [Text Word] OR “physical exercise training” [Text Word] OR
“pulmonary rehabilitation” [Text Word] OR “exercise rehabilitation” [Text Word] OR
“cardiopulmonary rehabilitation” [Text Word] OR “rehabilitation program#” [Text Word] OR
“exercise program#” [Text Word] OR “physical activity advice” [Text Word] OR “physical activity
counselling” [Text Word] OR “physical activity promotion” [Text Word] OR “accelerometer#”
[Text Word] OR “Pedometer#” [Text Word] OR “activity monitor#” [Text Word] OR “step count#”
[Text Word] OR [Text Word] OR “telerehabilitation” [Text Word] OR “e-Health intervention” [Text
Word])
3 (“Activity” [Text Word] OR “Motor activity” [Text Word] OR “physical inactivity” [Text Word] OR
“risk factor” [Text Word] OR “outcome assessment” [Text Word] OR “activity” [Text Word] OR
“step#” [Text Word] OR “walk#” [Text Word])
4 (Randomised controlled trial OR clinical trial OR experimental study)
5 1 AND 2 AND 3 AND 4
Text word includes all words and numbers in the title, abstract, other abstract, MeSH terms, MeSH
subheadings, publication types, substance names, personal name as subject, corporate author, secondary
source, comment/correction notes. #: all terms that begin with specific word.
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Results
The search strategy yielded 2582 potentially relevant articles. After removing 714 duplicates and screening
1868 abstract/titles, 55 articles remained for the full-text screening. On completion of full-text screening,
38 studies were excluded. Therefore, 17 studies were considered eligible for inclusion in this systematic
review and meta-analysis. One article provided three different comparisons, resulting in three RCTs. A full
PRISMA flow diagram of the screening process is shown in figure 1. Participants were individually
randomised in all included trials (i.e. there were no cluster RCTs). Characteristics of included RCTs are
summarised in table 2 and all were published between 2006 and 2018.
Characteristics of included subjects
All of the included trials comprised 1677 patients (45% male), with a median (range) sample size of 72
(16–343). Included patients had a mean (range) age of 66 (54–75) years and average FEV1 % pred ranged
from 43 to 78, indicative of mild-to-moderate COPD [34]. Patients were reported as physically inactive at
baseline with an average mean (range) value of 4365 (1557–7161) steps·day−1.
Characteristics of included/excluded trials
A total of 38 studies were excluded from this review on completion of full-text screening. The reasons for
exclusion include: the wrong intervention (n=11), duplicates (n=9), wrong study design (n=6), wrong outcomes
(n=6), wrong comparators (n=2), no full-text availability (n=2) and no reported data for daily steps (n=2).
Quality assessment
Table 3 provides a summary of the risk of bias decision made for each category for the included studies. In
line with the PEDro scale, the quality of included studies ranged from good to excellent (mean (interquartile
range) PEDro score 9.29 (1)); suggesting a low risk of bias towards the main outcome measure.
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Records after duplicates removed
(n=1868)
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(meta-analysis)
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FIGURE 1 PRISMA flow diagram for database search and study selection process.
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TABLE 2 Characteristics of included studies
First author [ref.] I/C Age years FEV1 % pred L Male/
female
Patient recruitment Intervention arm Control arm Type of
feedback
Weekly
goals
Time-points/
outcomes
ALTENBURG [14] 24/24 65 (58–72) 78 (66–95) 32/16 General practices
(primary care)
PA counselling 30 min ×5 sessions
using MI, GS and pedometer:
12 weeks
Received care appropriate to their
health status
Face-to-face No 3 months/daily
steps
AlTENBURG [14] 23/23 68 (61–72) 58 (40–69) 34/12 Outpatient hospital
clinics (secondary care)
PA counselling 30 min ×5 sessions
using MI, GS and pedometer:
12 weeks
Patients were recruited from
outpatient hospital clinics (secondary
care)
Received care appropriate to their
health status
Face-to-face No 3 months/daily
steps
ALTENBURG [14] 22/15 54±9.6 43±25.9 32/25 Pulmonary
rehabilitation centre
PA counselling (30 min ×5 sessions
using MI, GS and pedometer
12 weeks) added to PR 2 h 3 times per
week: 9 weeks
PR 2 h 3 times per week: 9 weeks Face-to-face No 3 months/daily
steps
ARBILLAGA-ETXARRI
[20]
220/293 69±9 58±17 448/65 Primary care and
5 hospital care centres
Six components: MI, urban walking
training walking, pedometer and
personalised calendar, phone updates,
exercise leaflet, group walking
sessions
General health counselling and info
booklet
Remote No 12 months/
daily steps
BENDER [21] 57/58 65±7 54.3±11 48/67 Pulmonary outpatient
clinics
Pedometer and personally selected
goals involving enjoyed activities of
daily living
A target of increasing 15% daily steps
per month for 3 months
Pedometer with no goal setting or
communication about physical activity.
A small 1-1 telephone call to
communicate daily steps
Remote No 3 months/daily
steps
CRUZ [15] 16/16 66.5±8.4 66.9±20.1 27/5 3 primary care centres
and a district hospital
PA-focused behavioural counselling
(average 25 min ×8 sessions using
SCT, SE, MI and pedometer and diary
feedback: 6 months) added to PR (1 h
3 times per week ET and 1.5 h once a
week EDU session: 3 months)
PR (1 h 3 times per week ET and 1.5 h
once a week EDU session: 3 months)
Face-to-face Yes 3 months/daily
steps
DE BLOK [22] 172/171 67±8 56±20 219/124 N/A Lifestyle PA counselling (3 min ×4
sessions using MI, GS and pedometer:
9 weeks) added to PR (9 weeks)
PR (9 weeks) Face-to-face No 9 weeks/daily
steps
DEMEYER [13] 172/171 67±8 56±20 219/124 6 rehabilitation centres
across Europe
Received the usual care plus the
tele-coaching platform
This includes a one-to-one interview,
a step counter and smartphone
coaching application
Received a standard leaflet explaining
the importance of PA in COPD as well
as information about PA
recommendations
Remote Yes 3 months/daily
steps
HOLLAND [23] 80/86 69±11 50±19 99/67 Pulmonary
rehabilitation waiting
list
Home rehabilitation, which involved a
pedometer and 7-weekly structured
telephone calls based around
motivational interviewing to improve
walking fitness
Centre-based rehabilitation with
encouragement to exercise at home,
no pedometer issued
Remote No 12 months/
daily steps
HORRNIX [24] 15/15 67±7 43±17 17/13 Hospitalised
exacerbation patients
Pedometer worn with telephone calls
three times per week for 1 month to
motivate and stimulate patients to
increase their PA levels
No contact and didn’t received any
motivational messages, just advice
about increasing PA before hospital
discharge
Remote Yes 1-month, daily
steps
Continued
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TABLE 2 Continued
First author [ref.] I/C Age years FEV1 % pred L Male/
female
Patient recruitment Intervention arm Control arm Type of
feedback
Weekly
goals
Time-points/
outcomes
HOSPES [25] 18/17 62±8 64±15 21/14 Outpatient clinic 12-week customised exercise
counselling to enhance daily physical
activity
Based on principles of goal setting
and implementation of goals
No counselling programmes Face-to-face No 3 months/daily
steps
KAWAGOSHI [26] 12/15 75±9 59.3±22 24/3 N/A Home-based rehabilitation in addition
to monitored daily physical activity
using pedometer and received
monthly feedback on physical activity
levels
Multidisciplinary home-based PR
programme for 12 months
Face-to-face No 12 months,
daily steps
MENDOZA [27] 52/50 68±8 66±19 62/40 Outpatient clinics at
private and public
hospitals
Received pedometer and physical
activity diary alongside counselling to
improve physical activity
Received counselling at each visit to
increase their physical activity levels
and advised to walk for at least 30 min
per day
Face-to-face No 3 months/daily
steps
MOY [28] 154/84 66±9 223/15 National Database of
Veterans
Pedometer and access to a website
with components including; step count
feedback, weekly goals, motivational
content to enhance activity levels
Wore pedometer and recorded steps.
Received no instruction about exercise
and were not assigned step goals or
website
Remote Yes 4 months/daily
steps
NOLAN [29] 76/76 69.0±9.0 50.5±21.2 110/42 Hospital-based PR unit Lifestyle PA counselling (30 mins ×8
sessions using GS and pedometer:
8 weeks) added to PR (1 h ×2 times
per week: 8 weeks)
PR (1 h ×2 time per week: 8 weeks) Face-to-face Yes 9 weeks/daily
steps
TABAK [30] 14/16 66±7 52±13 19/11 Hospital clinic Tele-rehabilitation intervention for
4 weeks
Received no tele-rehabilitation
Usual care was defined as usual
medication/physiotherapy
Remote Yes 1 month/daily
steps
VARAS [31] 21/19 67±8 49±16 31/9 Pulmonology
consultants
5 group physiotherapy sessions,
8 weeks counselling to increase daily
activity levels, through telephone
meetings
Informative sessions on the benefits of
exercise, pedometer issued but no
additional support
Remote Yes 8 weeks/daily
steps
VORRNIK [32] 84/73 62±9 55±17 78/79 Outpatient
physiotherapy practises
Consisted of two compartments:
1) smartphone application;
2) physiotherapist-based website
for providing real-time goals and
feedback for 6 months
No intervention Remote Yes 3 months/daily
steps
WAN [33] 57/52 68±8 61±21 95/14 General pulmonary
clinics
Pedometer and received access to a
website which provided four key
components; individualised goal
setting, iterative step-count feedback,
motivational content and online
community forum for 3 months
Received a pedometer and written
material about exercise but weren’t
assigned step-count goals
Remote Yes 3 months,
daily steps
Data are presented as n, mean±SD or mean (range). FEV1: forced expiratory volume in 1 s; PA: physical activity; N/A: not applicable; PR: pulmonary rehabilitation; MI: motivational
interviewing; GS: goal setting; SCT: social cognitive theory; SE: self-efficacy; ET: exercise training; EDU: education.
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TABLE 3 Qualitative synthesis of included studies using PEDro scale for the quality of randomised controlled trials
First author [ref.] Eligibility
criteria
Random
allocation
Concealed
allocation
Baseline
similarity
Blinding
(subject)
Blinding
(therapist)
Blinding
(assessor)
Measure
>85%
ITT Group
comparison
Point
measure
Quality
score
ALTENBURG [14] * * * * * * * * 8
ARBILLAGA-ETXARRI [20] * * * * * * * * * 9
BENDER [21] * * * * * * * 7
DE BLOK [22] * * * * * * * * 8
CRUZ [15] * * * * * * * * * * 10
DEMEYER [13] * * * * * * * * * 9
HOLLAND [23] * * * * * * * * * 9
HORRNIX [24] * * * * * * * 7
HOSPES [25] * * * * * * * 7
KAWAGOSHI [26] * * * * * * * * 8
MENDOZA [27] * * * * * * * * 8
MOY [28] * * * * * * * * 8
NOLAN [29] * * * * * * * * * * 10
TABAK [30] * * * * * * * * 8
VARAS [31] * * * * * * * * 8
VORRNIK [32] * * * * * * * * * 9
WAN [33] * * * * * * * * * 9
ITT: intention to treat. *: yes, score=1. The higher the given score, the better the quality. Cut-off points of the scale were: excellent (9–10), good (6–8), fair (4–5) and poor (3).
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Meta-analyses of included studies
When observing the effects of physical activity promotion, there was a positive effect on steps per day
compared with usual care (n=12 RCTs; 0.53 (0.29–0.77), p<0.00001) (figure 2) [13, 14, 20, 21, 24, 25, 27,
28, 30, 32, 33], which equated to an improvement of ∼1000 steps·day−1. A positive effect on steps per day
was also found when pedometer physical activity promotion was added to pulmonary rehabilitation versus
pulmonary rehabilitation alone (n=7 RCTs; 0.51 (0.13–0.88), p=0.006) (figure 2) [14, 15, 22, 23, 26, 30, 31].
However, the pooled analysis of pedometer physical activity promotion compared with usual care reported
considerable heterogeneity (I2=77%).
Moreover, the increases in daily physical activity induced by pedometer physical activity promotion (both
alone and alongside pulmonary rehabilitation), were comparable among studies that provided: 1) weekly or
infrequent goal setting; 2) an intervention length <3 months or >3 months; and 3) remote or face-to-face
contact following overall or subgroup analysis (all p<0.05) (table 4). In contrast, studies employing
accelerometers to measure physical activity were less effective compared with those employing pedometers.
Furthermore, patients with greater baseline physical activity levels (>4000 steps·day−1) exhibited greater
improvements in daily physical activity compared with those with lower baseline physical activity levels
(<4000 steps·day−1) (table 4).
Sensitivity analysis removing a single study [27] from the pooled analysis of pedometer-based physical
activity promotion reduced heterogeneity (I2=60%). The sensitivity analysis did not statistically affect the
pooled analysis of the remaining 11 studies in pedometer-based physical activity promotion (0.44 (0.25–
0.63); p<0.05).
Discussion
Summary of the main findings
This systematic review and meta-analysis of 19 RCTs provides evidence that pedometer physical activity
promotion as a standalone intervention compared with usual care or alongside pulmonary rehabilitation
Pedometer PA alone
ALTENBURG [14]
ARBILLAGA-ETXARRI [20]
ALTENBURG [14]
BENDER [21]
DEMEYER [13]
HORRNIX [24]
HOSPES [25]
MENDOZA [27]
MOY [28]
TABAK [30]
VORNIK [32]
WAN [33]
Subtotal (95% CI)
Heterogeneity: Tau2=0.12; Chi2=47.43, df=11 (p<0.00001); I2=77%
Test for overall effect: Z=4.39 (p<0.0001)
Mean
 
579
816
931
1114
870
984
785
9080
744
–163
–593
441
SD
 
3296
2852
8312
1907
2020
1926
2537
1983
1817
610
1830
1547
Activity promotion
Total
 
24
88
23
57
172
15
18
52
154
13
84
57
757
Mean
 
–27
65
–64
–305
–687
1013
–1367
138
–346
–639
–833
–105
SD
 
2970
2427
8463
1727
1763
821
2367
1649
1949
547
1631
1551
Usual care
Total
 
24
145
23
58
171
15
17
50
84
16
73
52
728
Weight %
 
7.2
10.5
7.0
9.2
10.9
5.8
5.9
8.4
10.4
5.4
10.0
9.2
100
Standard mean
difference IV, Random, 95% CI
Standard mean
difference IV, Random, 95% CI
ALTENBURG [14]
CRUZ [15]
DE BLOK [22]
HOLLAND [23]
KAWAGOSHI [26]
NOLAN [29]
VARAS [31]
Subtotal (95% CI)
Pedometer PA promotion + PR
Heterogeneity: Tau2=0.15; Chi2=17.93, df=6 (p=0.006); I2=67%
Test for overall effect: Z=2.63 (p=0.009)
–2
Usual care PA promotion
–1 0 21
Test for subgroup differences: Chi2=0.01, df=1 (p=0.90), I2=0%
 
1862
3279
1430
520
3540
727
3158
 
6216
2805
31106
2526
4395
6792
2191
22
13
8
80
15
76
17
231
184
–187
455
–160
849
892
–16
 
4660
1770
2177
3558
1760
5173
2795
15
13
8
86
12
76
16
226
 
14.0
10.5
9.1
21.2
11.8
20.9
12.4
100
Study or subgroup
 
 
0.19 (–0.38–0.76)
0.29 (0.02–0.55)
0.12 (–0.46–0.70)
0.78 (0.40–1.15)
0.82 (0.60–1.04)
–0.02 (–0.73–0.70)
0.86 (0.16–1.55)
1.60 (1.15–2.05)
0.44 (0.17–0.71)
0.80 (0.04–1.57)
0.14 (–0.18–0.45)
0.35 (–0.03–0.73)
0.53 (0.29–0.77)
  
0.29 (–0.37–0.95)
1.43 (0.55–2.31)
0.34 (–0.65–1.33)
0.22 (–0.09–0.52)
0.75 (–0.04–1.54)
–0.03 (–0.35–0.29)
1.24 (0.48–1.99)
0.51 (0.13–0.88)
FIGURE 2 Effect sizes of pedometer-based physical activity (PA) promotion on steps per day in patients with COPD. PR: pulmonary rehabilitation.
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compared with pulmonary rehabilitation alone improves steps per day by a magnitude that is within the
minimal important difference (MID) of 600–1100 steps·day −1 reported by DEMEYER et al. [35] (table 3).
Moreover, this meta-analysis suggests that pedometer physical activity promotion was more effective in
patients with greater baseline physical activity levels and when pedometers were used to measure
improvements in physical activity compared with accelerometers (table 4).
The addition of a sensitivity analysis reducing levels of heterogeneity provided no additional effects to the
pooled analysis of pedometer physical activity promotion.
Interpretation of the results
Previous literature surrounding the effects of physical activity promotion has reported inconclusive evidence
of the effectiveness of this intervention on steps per day. In agreement with the findings of our review,
QUI et al. [1] found that physical activity promotion improved steps per day compared with usual care in
nine studies. However, significant heterogeneity (I2=81%) may have affected the overall analysis of those
studies. The increase in steps per day reported as a result of pedometer physical activity promotion seems
much larger than those from other methods including exercise training as part of pulmonary rehabilitation,
health monitoring, long-term oxygen therapy or neuromuscular electrical stimulation [12, 17].
However, LAHHAM et al. [17] reported that physical activity promotion was not an effective standalone
intervention towards improving steps per day. A number of disparities are apparent between review
articles. First, LAHHAM et al. [17] based their analysis of physical activity promotion on a subgroup analysis
of subjective and objective measures. Both our study and that of QUI et al. [36] only included studies
reporting objective measures of daily physical activity due to limited validity and inaccuracy of subjective
measures of activity levels in patients with COPD [37]. Secondly, the number of included studies varied
across separate meta-analyses. In our review, a total of 12 studies with an average total sample size of 120
were included in the pooled analysis of pedometer physical activity promotion. Meanwhile, LAHHAM et al. [17]
reported only two studies on objective measures of physical activity, with an average total sample size
of 17. With the significant benefits of collecting and reporting objective measures of physical activity in
both healthy individuals and patients with COPD, and a much greater sample size across pooled analyses,
our review and that of QUI et al. [1] could be argued to have more valid findings for patients with COPD
than LAHHAM et al. [17]. Benefits of pedometer physical activity promotion have also been reported in
patients with type 2 diabetes [36]. A meta-analysis including 11 RCTs reported a significant increase in
physical activity with an average magnitude of improvement of 1822 steps·day −1, which is greater than we
found in patients with COPD (figure 3).
When observing the effects of physical activity promotion alongside pulmonary rehabilitation, the present
study and that by LAHHAM et al. [17] and QUI et al. [1] have shown statistically significant effects on steps
per day. LAHHAM et al. [17] stated that providing persistent and individualised feedback on activity levels in
TABLE 4 Subgroup analysis on physical activity (PA) outcomes of included studies
Subgroups Overall analysis Pedometer PA alone Pedometer PA promotion + PR
n Effect size I2 % n Effect size I2 % n Effect size I2 %
SMD 95% CI SMD 95% CI SMD 95% CI
Goal setting
Weekly 9 0.50 0.21–0.78 77 6 0.44 0.16–0.71 70 3 0.82 −0.23–1.88 88
Infrequent 10 0.55 0.24–0.85 75 6 0.64 0.19–1.09 84 4 0.29 0.04–0.54 0
Duration
<3 months 15 0.57 0.31–0.84 78 10 0.57 0.27–0.88 79 5 0.60 0.00–1.20 76
>3 months 4 0.34 0.18–0.50 0 2 0.36 0.17–0.55 0 2 0.35 −0.10–0.80 34
Type of feedback
Remote 10 0.47 0.27–0.67 68 8 0.46 0.24–0.68 67 2 0.67 −0.32–1.66 83
Face-to-face 9 0.60 0.14–1.06 81 3 0.70 −0.06–1.46 86 5 0.48 −0.03–0.99 65
Measure of PA
Accelerometer 8 0.38 0.09–0.67 79 4 0.36 −0.03–0.75 83 4 0.44 −0.04–0.91 74
Pedometer 11 0.64 0.35–0.92 69 8 0.64 0.31–0.97 75 3 0.63 0.00–1.26 48
Baseline PA levels
Low baseline PA 7 0.32 0.10–0.53 51 4 0.46 0.21–0.70 36 3 0.11 −0.10–0.33 0
High baseline PA 11 0.67 0.36–0.98 80 8 0.59 0.24–0.94 83 3 0.95 0.22–1.67 63
PR: pulmonary rehabilitation; SMD: standard mean difference.
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conjunction with pulmonary rehabilitation, achieved significant effects that exceeded both physical activity
promotion alone and pulmonary rehabilitation alone. However, LAHHAM et al. [17] were unable to include
a recent RCT [29]. Within that study, the authors reported evidence questioning the effectiveness of
physical activity promotion on daily physical activity in patients attending pulmonary rehabilitation [29].
It was determined that the routine use of this intervention should not be included in standard care
pulmonary rehabilitation because levels of daily physical activity were greater after pulmonary
rehabilitation alone when compared with baseline measures [29]. These results were based upon this study
being the first to include a large sample size, suggesting other studies were underpowered. In addition, that
study [29] scored highly on the PEDro scale, suggesting it had a low level of bias and the results reported
were of high quality. The present study and that by QUI et al. [1] have been able to incorporate the study
by NOLAN et al. [29] into separate meta-analyses. A contrast in reporting physical activity between our
study and that by QUI et al. [1] has provided two interpretations of the study by NOLAN et al. [29]. QUI
et al. [1] provided accelerometer step counts from baseline as a measure of steps per day from the study
by NOLAN et al. [29], reporting a small positive effect on physical activity levels. In contrast, we have
chosen to report steps per day from pedometer step counts, resulting in a neutral effect on physical
activity. We agree with QUI et al. [1] that accelerometers provide a more accurate measure of physical
activity; however, the majority of studies in our meta-analysis have primarily used pedometers to report
physical activity levels, so this may falsify results [29].
Our meta-analysis also suggests a number of important principles surrounding the way in which
pedometers have been used for promoting physical activity. An overall analysis of patients with greater
baseline physical activity levels (>4000 steps·day −1) showed greater improvements in steps per day
compared with those with lower baseline physical activity (⩽4000 steps·day−1) (figure 3). Of further
interest is the influence that baseline physical activity had on the effects of pedometer physical activity
promotion alongside pulmonary rehabilitation (table 4). In studies that implemented physical activity
promotion alongside pulmonary rehabilitation, an insignificant effect on steps per day was reported when
patients had a baseline physical activity ⩽4000 steps·day −1 [14, 15, 31]. It must be outlined that there was
only a small number of studies in this subgroup analysis with a small mean sample size; however, such
differences in effect size warrants closer scrutiny.
OSADNIK et al. [38] proposed that patients with COPD who exhibit greater exercise capacity prior to
pulmonary rehabilitation are more likely to achieve greater improvements in daily physical activity. They
reported clinically meaningful improvements in steps per day with patients reporting a 6MWD >350 m
compared with <350 m (707±1780 versus 157±1694 steps·day −1). This higher likelihood of improvement
in physical activity in patients preserving a greater exercise tolerance may also provide an explanation for
those patients exhibiting a higher baseline physical activity. However, in contrast with this notion, a recent
study from GULART et al. [39] suggests that patients with lower values of FEV1 and steps per day were
more likely to achieve MID in steps per day. This finding was attributed to the notion that patients with
more severe disease have a greater potential for improvement as they are further from their “maximal”
capacity, compared with patients with less severe disease.
In addition, our meta-analysis has found that the primary measure of physical activity (i.e. through
accelerometers or pedometers) may have marked influences on the effects of physical activity promotion (table 4).
FIGURE 3 Comparison between
improvements in daily steps shown
by various implementationmodalities.
Vertical dashed line indicates the
lower levels of minimal important
difference in patients with COPD. PA:
physical activity.
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Specifically, significant improvements in steps per day were shown in those studies reporting physical
activity via a pedometer compared with an accelerometer (figure 3). The finding in physical activity
outcomes may be due to accelerometers being a validated tool for measuring steps per day in patients with
COPD and therefore pedometers may overestimate physical activity [40]. However, a number of previous
studies, including QUI et al. [1], disagree with this finding. Both that study [1] and a meta-analysis in
patients with type 2 diabetes [41] have shown no significant differences between accelerometers and
pedometers. Consideration must be made in relation to these comparisons being indirect, with such
confirmation potentially required through a future 1 versus 1 design.
In contrast, pedometer physical activity promotion in patients with type 2 diabetes presents different findings.
For instance, it has been reported that patients with type 2 diabetes should initially set their own activity
goals, before they set to increase their goals with the assistance of healthcare professionals [36]. We were
unable to confirm this hypothesis among patients with COPD as many of the reported studies do not provide
definitive step goal descriptions. In addition, studies have shown that the use of step diaries alongside
pedometers as a source of motivation were imperative to increase physical activity levels [36, 42, 43].
Finally, it has become evident that regardless of the way pedometers are used (i.e. frequency of goal
setting, type of patient feedback, length of intervention, the instrument used to assess physical activity) or
the baseline activity levels, the improvement in steps per day is within the MID (figure 3) [35]. This
finding has strong implications for the use of pedometers as part of the comprehensive management of
patients with COPD.
Quality of the evidence
The overall quality of evidence from included studies was good, in line with the PEDro scale for quality
assessment. The inability to blind subjects reduced the overall quality of evidence and increased the risk of
bias towards the intervention procedure and may increase the chances of a placebo effect when using the
pedometer. Future research reporting the effects of physical activity promotion may improve quality
scoring by blinding all subjects from the intervention procedure. However, a concern remains that blinding
patients from the intervention would require a pedometer being issued to a control group, which may
present the control group with a level of physical activity promotion as they are able to monitor their daily
steps. A number of studies were unable to blind any members of the study from patient allocation [14, 21,
24, 25, 28, 30]. In any clinical trial, blinding of at least the researcher is desirable and the blinding of
subjects is warranted in order to decrease bias within the findings. When blinding is not used or the
subject group status is easily detectable, subjects will generally try to fulfil the perceived expectation of the
researcher [44].
Strength and limitations
This systematic review and meta-analysis is the first to include two recently published RCTs reporting
pedometer-based physical activity promotion implemented either alone [20] or alongside a combined
pulmonary rehabilitation programme [31]. Moreover, we are the first to report that, regardless of how
pedometers are used in the implementation of physical activity promotion, they can provide improvements
in daily physical activity (steps per day) which exceed the MID. Several limitations should be noted. First,
some heterogeneity existed in the outcomes of pedometer physical activity promotion, which was partially
explained by our findings on the modalities of pedometer use. Secondly, we cannot be certain of the
specific improvement a pedometer intervention can have alongside pulmonary rehabilitation on daily
physical activity without knowing the exact progression of exercise training for individual patients during
pulmonary rehabilitation. Finally, despite a comprehensive search of the literature using the main scientific
search databases, there is still a possibility that studies eligible for inclusion may have been missed. The
search restriction on English written studies and the failure to search for unpublished studies and/or
abstracts/conference papers may have resulted in selection and publication bias.
Conclusion
In conclusion, our systematic review and meta-analysis provides evidence that pedometer-based physical
activity promotion promotes steps per day when it is used as an intervention alone or alongside
pulmonary rehabilitation, including two recently published RCTs [20, 31]. Future trials should concentrate
on high-quality study designs, with specific thought towards the optimal way of using pedometers during
physical activity promotion (i.e. consider frequency of goal setting, type of patient feedback, length of
intervention and instrument used for assessing physical activity). This review has found further evidence
that patients benefit more from physical activity promotion when baseline levels of physical activity are
>4000 steps·day−1. Therefore, consideration of baseline daily physical activity levels and/or exercise
tolerance [38], should feature prominently in future studies. Furthermore, future studies should investigate
the combined benefits of pulmonary rehabilitation, physical activity promotion and cognitive behavioural
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therapy for those patients with severe COPD who are anxious and depressed and therefore exhibit
limitations in improving daily physical activity. Moreover, future studies could incorporate the addition of
semi-automated tele-coaching as delivered by DEMEYER et al. [7], as a low maintenance approach to
providing continued support towards daily physical activity feedback [38].
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